Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Complementary and Integrative Medicine

Editor-in-Chief: Lui, Edmund

Ed. by Ko, Robert / Leung, Kelvin Sze-Yin / Saunders, Paul / Suntres, PH. D., Zacharias

CiteScore 2017: 1.41

SCImago Journal Rank (SJR) 2017: 0.472
Source Normalized Impact per Paper (SNIP) 2017: 0.564

See all formats and pricing
More options …

Emblica officinalis – Anti-obesity activity

Iram Nazish / Shahid H Ansari
  • Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Hamdard University, Hamdard Nagar, New Delhi, India
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2017-12-05 | DOI: https://doi.org/10.1515/jcim-2016-0051



Emblica officinalis Gaertn. (family-Phyllanthaceae) fruits, known commonly as amla, is extensively used in Indian traditional system of medicine for the treatment of various disorders. The ethanolic E. officinalis extract is reported to have various activity such as antidiabetic, antihyperlipidemic and antioxidant activity in experimental animals.


To evaluate anti-obesity effect of aqueous E. officinalis extract in murine model of high fat diet (HFD)-induced obesity.

Materials and methods

Male Wistar rats fed with HFD (20 g/day/rat, p.o) for a period of 42 days were used to induce obesity. Aqueous E. officinalis extract (20 mg/kg bw) administered orally to HFD-fed rats from day 8 to 50 days for a period of 42 days. Body weight gain, serum lipids, insulin and leptin parameters were measured.


Oral feeding of the aqueous E. officinalis extract (20 mg/kg) to HFD-induced obese rats for a period of 42 days resulted in significant reduction in body weight gain, insulin, leptin, lipids as compared to rats fed HFD alone. Further, the extract also showed significant increase in high density lipoprotein (HDL-C) levels.

Discussion and conclusions

These results show that aqueous E. officinalis extract possess significant anti-obesity potential.

Keywords: Emblica officinalis; high-fat diet; insulin; leptin; rat


  • [1]

    Haslam DW, James WPT. Obesity. Lancet. 2005;366:1197–209.CrossrefPubMedGoogle Scholar

  • [2]

    Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [3]

    LeBlanc ES, O’Connor E, Wtitlock PD, Patnode CD, Kapka T. Effectiveness of primary care -relevant treatments for obesity in adults: a systematic evidence review for the U. S. Preventive Services Task Force. Ann Int Med. 2011;155:434–47.CrossrefGoogle Scholar

  • [4]

    Chaput JP, St-Pierre S, Tremblay A. Currently available drugs for the treatment of obesity: sibutramine and orlistat. Mini Rev Med Chem. 2007;7:3–10.PubMedWeb of ScienceCrossrefGoogle Scholar

  • [5]

    Karamadoukis L, Shivashankar GH, Ludeman L, Williams AJ. An unusual complication of treatment with orlistat. Clin Nephrol. 2009;71:430–32.PubMedCrossrefGoogle Scholar

  • [6]

    Mayer MA, Hocht C, Puyo A, Taira CA. Recent advances in obesity pharmacotherapy. Curr Clin Pharmacol. 2009;2009(4):53–61.Google Scholar

  • [7]

    Rayalam S, Della-Fera MA, Baile CA. Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem. 2008;2008(19):717–26.Web of ScienceGoogle Scholar

  • [8]

    Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome – a review. Phytochemistry. 2009;70:11–24.Web of SciencePubMedCrossrefGoogle Scholar

  • [9]

    Jain SK, Khurdiya DS. Vitamin C enrichment of fruit juice based ready-to serve beverages through blending of Indian gooseberry (Emblica officinalis Gaertn.) juice. Plant Foods Hum Nutr. 2004;59(2):63–66.PubMedCrossrefGoogle Scholar

  • [10]

    Suryanarayan P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis. 2007;24(13):1291–97.Google Scholar

  • [11]

    Dhanalakshmi S, Devi RS, Srikumar R, Muruganandam AV, Kumar V, Manikandan S, et al. Protective effect of Triphala on cold stress-induced behavioral and biochemical abnormalities in rats. Yakugaku Zasshi. 2007;127(11):1863–67.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [12]

    Anonymous. Indian Pharmacopoeia. New Delhi, India: Government of India, 1996.Google Scholar

  • [13]

    Trease GE, Evans WC. Pharmacognosy. Philadelphia: Bailliere Tindal Publisher and distributer, 1989.Google Scholar

  • [14]

    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMedGoogle Scholar

  • [15]

    Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte DJ, Schwartz MW. Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high fat feeding. Am J Physiol Endocrinol Metab. 1999;277:659–66.CrossrefGoogle Scholar

  • [16]

    Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes. 1991;40:1397–403.CrossrefPubMedGoogle Scholar

  • [17]

    Mooradian AD, Chehade J, Hurd R, Haas MJ. Monosaccharide-enriched diets cause hyperleptinemia without hypophagia. Nutrition. 2000;16:439–41.PubMedCrossrefGoogle Scholar

  • [18]

    Brown JL, Spicer MT, Spicer LJ. Effect of high-fat diet on body composition and hormone responses to glucose tolerance tests. Endocrine. 2002;19:327–32.PubMedCrossrefGoogle Scholar

  • [19]

    K V A, Dikeakos A, Sclafani A. High Dietary Fat Promotes Syndrome X in Nonobese rats. J Nutr. 2003;133:2244–49.PubMedCrossrefGoogle Scholar

  • [20]

    O’Shaughnessy IM, Myeres TJ, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, et al. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995;26:186–92.CrossrefPubMedGoogle Scholar

  • [21]

    Gabriely I, Ma XH, Atzmon G, Rajala MW, Berg AH, Scherer P, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process. Diabetes. 2001;51:2951–58.Google Scholar

  • [22]

    Alam I, Lewis K, Stephenes JW, Baxter JN. Obesity, metabolic syndrome and sleep apnoea: all proinflammatory states. Obes Rev. 2006;8:119127.Google Scholar

  • [23]

    Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–70.CrossrefPubMedGoogle Scholar

  • [24]

    Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2000;95:3584–89.CrossrefPubMedGoogle Scholar

About the article

Received: 2016-05-31

Accepted: 2017-10-09

Published Online: 2017-12-05

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Citation Information: Journal of Complementary and Integrative Medicine, Volume 15, Issue 2, 20160051, ISSN (Online) 1553-3840, DOI: https://doi.org/10.1515/jcim-2016-0051.

Export Citation

© 2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in